Navigation Links
Reportlinker Adds Bevacizumab - Comprehensive Patent Search

NEW YORK, Feb. 1, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Bevacizumab - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.

Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

This Pipeline Developer report covers Bevacizumab

Bevacizumab indications: In combination with 5-Fluorouracil based chemotherapy for metastatic carcinoma of the colon or rectum; in combination with Carboplatin and Paclitaxel for non-squamous, non-small cell lung cancer; in combination with Paclitaxel for metastatic breast cancer

Bevacizumab innovator: Roche (Avastin)

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.

Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.

Pipeline Developer features: # Comprehensive patent searching, covering the world's key territories (see 'search coverage' below)

# Identifies patents covering molecule, formulation, process, use, combination and assay techniques (see 'Patent Categories Identified' below)

# Patent identification, categorisation and interpretation

# Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims

# Manual filtration of patents not relevant to generic development

# Updated on a monthly basis, including changes to patent families, statuses, and litigation

# Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers

Patent Categories Identified: 1. Molecular Form

a) Molecule Patents

b) Salts, Hydrates & Solvates

c) Polymorphic Forms

d) Other Molecular Forms

2. Active Ingredient Preparation

a) Intermediates & Preparation Thereof

b) Final Synthetic Stages

c) Complete Synthesis

d) Purification Methods

e) Fermentation Methods

f) Biotechnology

3. Formulations & Methods Thereof

a) General Formulations & Methods

b) Injectable Formulations

c) Oral Formulations

d) Other Administration-Specific Formulations

e) Excipients, Kits & Packaging

4. Related Medical Use & Administration

a) New Use Related to Main Indication

b) Dosing Regimen/Administration Conditions

5. Active Ingredient Combinations

a) Novel Combinations

b) Use of Combinations

c) Dosing Regimen & Administration Conditions for Combinations

6. Analytical Methods

a) Assaying Methods

b) Methods of Determining Patient Suitability

Search coverage: Clicking on a patent family displays detailed information on the 'Core' and 'Non-Core' 'Patent Family Equivalents'. 'Core Patent Family Equivalents' are equivalent patents from territories that are individually verified and monitored for changes, including British, German, Spanish, French, US, Canadian, Australian, European, and PCT patents. Statuses are also monitored and updated. 'Extended Patent Family Equivalents' are equivalent patents found through the INPADOC database, increasing the search coverage to 70 countries.

Patent and national register access:Clicking on a listed patent/application number or text or image link will launch a pop-up window containing an image of the patent, enabling easy analysis of the patent documents. Clicking on a register link launches a pop-up window with the patent office register extract for that patent. This allows investigation into the examination status of a pending patent, opposition of a granted patent and/or payment of maintenance fees. Please note that no extra charges apply to accessing or downloading documents of any kind.

Litigation alerts:Informing you of developments in court, litigation alerts can also be accessed by clicking on the litigation symbol next to the status, with links to judgments where available.

Updating:To take the time and hassle out of monitoring and updating a large number of patents, all Pipeline Developer reporting is updated on a monthly basis. Convenient change flags identify new patent families, new patent family members, changes in statuses and litigation alerts.

Legal status and transaction history:You can also find legal status and transaction history for 'Extended Patent Family Equivalents' by clicking on the INPADOC Family/Legal Status button for 65 additional territories.

Reporting and access:All data can be exported into Microsoft Excel and print friendly versions for ease of data manipulation and reporting. Company details are confidential and all data is SSL secure. Five users per company are permitted and access levels are controlled by a nominated 'company administrator'.

Pipeline Developer is just one of the benchmark products from GenericsWeb's Pipeline Patent Intelligence product suite.

To order this report:: Bevacizumab - Comprehensive patent search

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!CONTACT:  Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects
2. Reportlinker Adds The 2011 US Coagulation Market
3. Reportlinker Adds In-vitro and Companion Diagnostics Industry - 2010 Yearbook
4. Reportlinker Adds X-Ray Systems Market to 2016 - The Digital X-Ray Systems Segment to be the Growth Driver
5. Reportlinker Adds The 2011 Top Ten Worlds Leading Pharmaceutical Companies
6. Reportlinker Adds The 2011 Top Ten Worlds Leading Diagnostic Imaging Companies
7. Reportlinker Adds The Drug Discovery Outsourcing Market
8. Reportlinker Adds The Top 10 CMOs in China
9. Reportlinker Adds Brand Erosion Post-Patent Expiry - An analysis of small molecule brand erosion post-patent expiry
10. Reportlinker Adds The 2011 Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
11. Reportlinker Adds Emerging Regional Markets for Therapeutic Drugs
Post Your Comments:
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Japanese therapeutic drug monitoring market, including emerging ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the Global Cell Surface Testing Market: ... report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... November 26, 2015 ... universitetssjukhus ser potential att använda SyMRI för ... för patienter med multipel skleros (MS) ... med SyntheticMR AB för att kunna använda ... sjukhuset. Med SyMRI kan man generera flera ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... where preparing the perfect dish and pleasing the palates of attendees is of ... bringing a dish to a seasonal get-together, give these recipes a try this ...
(Date:11/25/2015)... NV (PRWEB) , ... November 25, 2015 , ... Dr. ... patients to learn more about hair loss treatment with the Capillus272™ Pro laser therapy ... effective solution for thicker and fuller hair, without the need for surgery, prescription pills, ...
(Date:11/25/2015)... ... , ... According to an article published November 10th by The ... as a breakthrough for performing hernia repairs. The article explains that the biggest advantage ... it can greatly reduce the pain that a patient might otherwise experience after a ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... for physicians and athletic programs, launches new Wimbledon Athletics Facebook page ... testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under the age ...
(Date:11/25/2015)... ... 25, 2015 , ... SCOTTSDALE, AZ) - Today, Dr. ... both surgical and non-surgical treatments, announced the expansion of his private practice capabilities ... , Highly trained and nationally recognized for his natural approach, Dr. Todd ...
Breaking Medicine News(10 mins):